… Our results showed that resveratrol supplementation significantly reduced levels of TNF-alpha
(SMD = −0.46; 95% CI (−0.78, 0.14); P = 0.005) and hs-CRP (SMD = −0.53; 95% CI (−1.01…

… of resveratrol supplementation. The results of this meta-analysis demonstrate that resveratrol
supplementation, … , did not produce benefits to patients with non-alcoholic fatty liver disease …

… with type 2 diabetes mellitus (T2DM) are prone to develop non-alcoholic fatty liver …
resveratrol supplementation improves novel hepatic and cardiovascular indices in these patients…

… on liver enzymes in non-alcoholic fatty liver disease (NAFLD) … of resveratrol supplementation
on alanine aminotransferase (ALT), and aspartate aminotransferase (AST) levels in patients …

… DM2 individuals supplemented with 800 mg/day of resveratrol for … in the lipoproteins or
inflammatory biomarkers. In contrast, in … , the resveratrol supplementation improved all biomarkers …

… Our findings indicate that resveratrol supplementation could decrease FGC in patients with
T2D, but the effect was too small to be considered clinically important. In the case of MetS, it …

… This study aimed to evaluate the effect of resveratrol on liver biomarkers in adult participants,
using systematic review and meta-analysis of randomized controlled trials. PubMed, …

Full article: Effects of combined therapy with resveratrol, continuous and interval exercises
on apoptosis, oxidative stress, and inflammatory biomarkers in the liver of old rats with non-…

… RCTs that assessed the effects of resveratrol on these mediators have indicated controversy,
this meta-analysis aimed to assess the effect of resveratrol on inflammatory biomarkers. …

… Conclusion: These findings indicated that resveratrol supplementation in dose and duration
… in NAFLD patients. Further studies are warranted to explain more effects of resveratrol on …